Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Moderna : Foreigners net buyers of Japanese stocks for third week in a row

11/27/2020 | 02:15am EST

Nov 27 (Reuters) - Foreign investors remained net buyers of Japanese equities for a third straight week that ended Nov. 20, buoyed by progress in a second coronavirus vaccine-related developments that rekindled hopes of a swift global economic recovery.

Overseas investors were net buyers of stocks worth 597.17 billion yen ($5.74 billion) last week, after purchasing over 1 trillion yen in each of the previous two weeks, data from Japanese exchanges showed.

They bought 333.18 billion yen in cash equities markets and 263.99 billion yen worth of derivatives.

Moderna Inc said its experimental COVID-19 vaccine was 94.5% effective in preventing infection based on interim late-state data, which spurred investor sentiment last week.

The optimism, however, faded partially as Tokyo raised its coronavirus alert to the highest level latter last week due to a sharp increase in coronavirus cases.

The Topix index rose 1.4% while the Nikkei share average added 0.6% last week, both marking a third straight week of gains.

Meanwhile, Japanese investors sold overseas equities worth 1.43 trillion yen last week, marking their biggest weekly net selling since mid-July, finance ministry data showed. ($1 = 104.0300 yen)

(Reporting by Gaurav Dogra and Patturaja Murugaboopathy; Editing by Rashmi Aich)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
MODERNA, INC. -3.58% 125.01 Delayed Quote.19.66%
NIKKEI 225 -0.38% 28523.26 Real-time Quote.2.91%
All news about MODERNA, INC.
02:51aS.Korea in talks to secure 40 mln doses of Novavax's COVID-19 vaccine
RE
02:26aCOVID-19 vaccine shots add to confusion over China's tests for travellers
RE
01:00aMODERNA : CDC says 15.7 mln doses of COVID-19 vaccines administered in United St..
RE
01/19MODERNA : Pharmacist charged in attempt to ruin COVID-19 vaccine
AQ
01/19U.S. exceeds 400,000 coronavirus deaths
RE
01/19B.C. TO STILL ADMINISTER SECOND DOSE : Dix
AQ
01/19U.S. exceeds 400,000 coronavirus deaths
RE
01/19MODERNA : Calif. Health Officials Halt Covid-19 Vaccinations from Moderna Lot No..
MT
01/19ASTRAZENECA : India to start COVID vaccine exports on Wednesday
RE
01/19ASTRAZENECA : India to start COVID vaccine exports on Wednesday
RE
More news
Financials (USD)
Sales 2020 511 M - -
Net income 2020 -561 M - -
Net cash 2020 2 597 M - -
P/E ratio 2020 -104x
Yield 2020 -
Capitalization 49 468 M 49 468 M -
EV / Sales 2020 91,7x
EV / Sales 2021 4,18x
Nbr of Employees 1 100
Free-Float 90,0%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 136,60 $
Last Close Price 125,01 $
Spread / Highest target 48,0%
Spread / Average Target 9,27%
Spread / Lowest Target -44,8%
EPS Revisions
Managers and Directors
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
Noubar B. Afeyan Chairman
David W. Meline Chief Financial Officer
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.19.66%49 468
LONZA GROUP AG1.97%48 472
CELLTRION, INC.-12.95%38 667
IQVIA HOLDINGS INC.5.47%36 230
SEAGEN INC.7.75%34 149
HANGZHOU TIGERMED CONSULTING CO.,LTD-1.58%21 275